Groundbreaking 3D printable prosthesis could offer amputees a low-cost solution to restore finger functionality

A groundbreaking, easy-to-use 3D printable finger prosthesis created by a recent University of Houston graduate could offer amputees a low-cost solution to restore finger functionality.

Neurocrine bags FDA approval for new ‘sprinkle’ Ingrezza formulation

Ingrezza generated $506m in revenue in Q1 2024, as per Neurocrine’s financials. Image Credit: Panchenko Vladimir / Shutterstock. The US Food and Drug Administration (FDA)

May 1, 2024

Study discovers new mechanism for deadly tumor switch in prostate cancer

A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable

August 15, 2023

UnitedHealth pushed employees to follow an algorithm to cut off Medicare patients’ rehab care

The nation’s largest health insurance company pressured its medical staff to cut off payments for seriously ill patients in lockstep with a computer algorithm’s calculations,

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.